Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis
| Status: | Completed |
|---|---|
| Conditions: | Hematology |
| Therapuetic Areas: | Hematology |
| Healthy: | No |
| Age Range: | Any - 18 |
| Updated: | 6/11/2016 |
| Start Date: | April 2010 |
| End Date: | April 2016 |
An Open Label Phase II Pilot Study of Hybrid ImmunoTherapy(ATG/Dexamethasone/Etoposide) for Hemophagocytic LymphoHistiocytosis:HIT-HLH
Despite good progress during the last decade, hemophagocytic lymphohistiocytosis (HLH)
remains difficult to treat. Two different treatment regimens have been used successfully.
The first one, a treatment regimen based on two drugs called etoposide and dexamethasone,
has been used worldwide. The second regimen, based on two drugs called Anti-thymocyte
globulin (ATG) and prednisone, has been used mostly at one hospital in Paris, for over 15
years. With either regimen, about three quarters of treated children survive the most
difficult time, the first two months after diagnosis. These two different regimens appear to
work somewhat differently, and we suspect that combining them may give better results than
either regimen alone. We are conducting this clinical trial to test the combination of ATG,
dexamethasone, and etoposide for the treatment of HLH.
The purpose of this research study is to find out what effects (good and bad) this drug
combination has on you and your HLH.
remains difficult to treat. Two different treatment regimens have been used successfully.
The first one, a treatment regimen based on two drugs called etoposide and dexamethasone,
has been used worldwide. The second regimen, based on two drugs called Anti-thymocyte
globulin (ATG) and prednisone, has been used mostly at one hospital in Paris, for over 15
years. With either regimen, about three quarters of treated children survive the most
difficult time, the first two months after diagnosis. These two different regimens appear to
work somewhat differently, and we suspect that combining them may give better results than
either regimen alone. We are conducting this clinical trial to test the combination of ATG,
dexamethasone, and etoposide for the treatment of HLH.
The purpose of this research study is to find out what effects (good and bad) this drug
combination has on you and your HLH.
Hemophagocytic lymphohistiocytosis (HLH) is a rare immunological disorder first recognized
almost 70 years ago.(1) Genetic and animal studies have indicated that the familial form of
HLH is clearly due to a deficiency of cytotoxic killing. Patients with HLH present with a
potentially fatal syndrome of 'hyperimmunity.' These patients have severe inflammation,
associated with cytopenias and variably severe bone marrow, liver, or CNS damage. Tissue
damage and mortality appear to be due to hypercytokinemia related to persistent immune
hyperactivation. An animal model of HLH and correlative human studies all suggest that
excessive and abnormal activation of T cells drives the pathophysiology of this disorder,
and that suppressing this excessive activation is critical for successful therapy of HLH. It
is believed a combination of the two proven induction regimens for hemophagocytic
lymphohistiocytosis (HLH) (anti-thymocyte globulin (ATG)- and etoposide-based) will result
in response rates and overall survival rates at eight weeks which are comparable or better
than the current standard of care (induction therapy per the HLH-94 protocol).
almost 70 years ago.(1) Genetic and animal studies have indicated that the familial form of
HLH is clearly due to a deficiency of cytotoxic killing. Patients with HLH present with a
potentially fatal syndrome of 'hyperimmunity.' These patients have severe inflammation,
associated with cytopenias and variably severe bone marrow, liver, or CNS damage. Tissue
damage and mortality appear to be due to hypercytokinemia related to persistent immune
hyperactivation. An animal model of HLH and correlative human studies all suggest that
excessive and abnormal activation of T cells drives the pathophysiology of this disorder,
and that suppressing this excessive activation is critical for successful therapy of HLH. It
is believed a combination of the two proven induction regimens for hemophagocytic
lymphohistiocytosis (HLH) (anti-thymocyte globulin (ATG)- and etoposide-based) will result
in response rates and overall survival rates at eight weeks which are comparable or better
than the current standard of care (induction therapy per the HLH-94 protocol).
Inclusion Criteria:
- diagnosis of hemophagocytic lymphohistiocytosis
- Patients <18 years of age
- The patient must have active disease at the time of enrollment
- Patient's legal guardians must sign an Institutional Review Board approved consent
form indicating their awareness of the investigational nature and the risks of this
study.
- Eligible subjects must be enrolled with the protocol coordinating center
Exclusion Criteria:
- Recent treatment, within 3 months, with another therapeutic regimen for HLH
- Known active malignancy
- Known rheumatologic diagnosis which may be the underlying cause of HLH
- Pregnancy (as determined by serum or urine test) or active breast feeding
- Failure to provide signed informed consent
We found this trial at
15
sites
Stanford University Stanford University, located between San Francisco and San Jose in the heart of...
Click here to add this to my saved trials
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
Cincinnati, Ohio 45229
1-513-636-4200
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
Click here to add this to my saved trials
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
Click here to add this to my saved trials
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
Portland, Oregon 97239
503 494-8311
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Phoenix Children's Hospital Phoenix Children's Hospital has provided hope, healing, and the best healthcare for...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
111 Michigan Ave NW
Washington, District of Columbia
Washington, District of Columbia
(202) 476-5000
Childrens National Medical Center As the nation’s children’s hospital, the mission of Children’s National Medical...
Click here to add this to my saved trials
Click here to add this to my saved trials